Class information for:
Level 1: PROTEASE ACTIVATED RECEPTOR//PROTEASE ACTIVATED RECEPTORS//THROMBIN RECEPTOR

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1383 2593 44.7 90%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1045 9625 BOWMAN BIRK INHIBITOR//PROTEASE ACTIVATED RECEPTOR//CYCLOTIDES

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PROTEASE ACTIVATED RECEPTOR Author keyword 136 61% 6% 143
2 PROTEASE ACTIVATED RECEPTORS Author keyword 116 63% 5% 117
3 THROMBIN RECEPTOR Author keyword 101 62% 4% 105
4 PROTEASE ACTIVATED RECEPTOR 2 Author keyword 97 61% 4% 104
5 PAR 2 Author keyword 93 56% 4% 114
6 THROMBIN Author keyword 88 15% 22% 561
7 PROTEINASE ACTIVATED RECEPTOR 2 Author keyword 80 77% 2% 54
8 PROTEINASE ACTIVATED RECEPTORS Author keyword 48 73% 1% 36
9 PROTEINASE ACTIVATED RECEPTOR Author keyword 46 65% 2% 44
10 PAR 1 Author keyword 39 36% 3% 88

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 PROTEASE ACTIVATED RECEPTOR 136 61% 6% 143 Search PROTEASE+ACTIVATED+RECEPTOR Search PROTEASE+ACTIVATED+RECEPTOR
2 PROTEASE ACTIVATED RECEPTORS 116 63% 5% 117 Search PROTEASE+ACTIVATED+RECEPTORS Search PROTEASE+ACTIVATED+RECEPTORS
3 THROMBIN RECEPTOR 101 62% 4% 105 Search THROMBIN+RECEPTOR Search THROMBIN+RECEPTOR
4 PROTEASE ACTIVATED RECEPTOR 2 97 61% 4% 104 Search PROTEASE+ACTIVATED+RECEPTOR+2 Search PROTEASE+ACTIVATED+RECEPTOR+2
5 PAR 2 93 56% 4% 114 Search PAR+2 Search PAR+2
6 THROMBIN 88 15% 22% 561 Search THROMBIN Search THROMBIN
7 PROTEINASE ACTIVATED RECEPTOR 2 80 77% 2% 54 Search PROTEINASE+ACTIVATED+RECEPTOR+2 Search PROTEINASE+ACTIVATED+RECEPTOR+2
8 PROTEINASE ACTIVATED RECEPTORS 48 73% 1% 36 Search PROTEINASE+ACTIVATED+RECEPTORS Search PROTEINASE+ACTIVATED+RECEPTORS
9 PROTEINASE ACTIVATED RECEPTOR 46 65% 2% 44 Search PROTEINASE+ACTIVATED+RECEPTOR Search PROTEINASE+ACTIVATED+RECEPTOR
10 PAR 1 39 36% 3% 88 Search PAR+1 Search PAR+1

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 THROMBIN RECEPTOR 463 57% 21% 544
2 PAR 2 291 88% 5% 140
3 TETHERED LIGAND 193 97% 2% 57
4 AGONIST PEPTIDES 147 94% 2% 51
5 PROTEOLYTIC MECHANISM 102 73% 3% 78
6 PROTHROMBIN MESSENGER RNA 83 74% 2% 62
7 NEUROGENIC MECHANISM 71 84% 1% 38
8 RECEPTOR 2 ACTIVATING PEPTIDES 56 100% 1% 19
9 ALPHA THROMBIN 56 26% 7% 182
10 PROTEASE ACTIVATED RECEPTOR 1 49 38% 4% 101

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Protease-activated receptors: Contribution to physiology and disease 2004 590 310 77%
Targeting proteinase-activated receptors: therapeutic potential and challenges 2012 75 214 77%
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease 2014 13 54 78%
Proteinase-activated receptors 2001 797 400 68%
Structure, function and pathophysiology of protease activated receptors 2011 75 492 71%
Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection 2015 1 69 68%
Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response 2005 307 444 80%
International Union of Pharmacology. XXVIII. Proteinase-activated receptors 2002 269 103 92%
Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent 2015 1 92 46%
Protease-activated receptors as drug targets in inflammation and pain 2009 47 141 85%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DIABET ENDOCRINE GRP 15 68% 0.5% 13
2 GRP PHARMACOL HEMOSTASEOL 12 86% 0.2% 6
3 MUCOSAL INFLAMMAT GRP 8 24% 1.1% 28
4 DAIICHI 7 57% 0.3% 8
5 ENDOCRINE GRP 7 31% 0.7% 18
6 KEY IMMUNOPHARMACOL GUANGDONG PROV 7 67% 0.2% 6
7 CANADIAN HLTH PROTEINASES INFLAMMAT NE 6 100% 0.2% 4
8 KEY IMMUNOPHARMACOL GUANGDONG PROVINCE 6 100% 0.2% 4
9 NEUROBIOL 151 5 63% 0.2% 5
10 ZENTRUM VASK BIOL MED ERFURT 4 75% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000082729 TUMOR ASSOCIATED TRYPSIN INHIBITOR//TATI//PEC 60
2 0.0000081472 NEUROSERPIN//PROTEASE NEXIN 1//PN 1
3 0.0000054731 HIRUDIN//FACTOR XA//THROMBIN INHIBITOR
4 0.0000053437 ACTIVATED PROTEIN C//ENDOTHELIAL PROTEIN C RECEPTOR//DROTRECOGIN ALFA ACTIVATED
5 0.0000052472 GALBULIMIMA ALKALOIDS//GALBULIMIMA BELGRAVEANA//HIMBACINE
6 0.0000050700 PATHOL HSC4N67//LIVER CLEARANCE//SERP 1
7 0.0000050236 NETHERTON SYNDROME//KALLIKREINS//KALLIKREIN RELATED PEPTIDASES
8 0.0000047508 CANCER PROCOAGULANT//TISSUE FACTOR//CANCER ASSOCIATED THROMBOSIS
9 0.0000043828 SPECIALTY CARE SERV//PULM CRIT CARE MEDMED//ANTIPLASMINS
10 0.0000040075 G ALPHA12//G ALPHA16//G ALPHA 16